HomeCSL • ASX
CSL Ltd
$287.92
Mar 28, 7:00:00 PM GMT+11 · AUD · ASX · Disclaimer
StockAU listed securityAU headquartered
Previous close
$286.35
Day range
$286.98 - $289.76
Year range
$228.65 - $312.99
Market cap
139.14B AUD
Avg Volume
728.25K
P/E ratio
36.89
Dividend yield
1.13%
Primary exchange
ASX
CDP Climate Change Score
D
Financials
Income Statement
Revenue
Net income
(USD)Dec 2023Y/Y change
Revenue
4.03B12.10%
Operating expense
859.00M-0.12%
Net income
950.50M17.13%
Net profit margin
23.614.52%
Earnings per share
EBITDA
1.52B20.95%
Effective tax rate
19.29%
Total assets
Total liabilities
(USD)Dec 2023Y/Y change
Cash and short-term investments
1.02B-32.56%
Total assets
37.30B5.24%
Total liabilities
18.14B3.28%
Total equity
19.16B
Shares outstanding
483.09M
Price to book
8.05
Return on assets
8.76%
Return on capital
10.45%
Net change in cash
(USD)Dec 2023Y/Y change
Net income
950.50M17.13%
Cash from operations
534.50M9.08%
Cash from investing
-351.00M93.69%
Cash from financing
-407.00M-163.30%
Net change in cash
-249.00M94.39%
Free cash flow
644.44M61.06%
About
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
Founded
1916
Website
Employees
32,065
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu